(Q34477439)

2 August 2017

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial (English)

1 reference

2 August 2017

phase III clinical trial

0 references

placebo

0 references

traumatic brain injury

0 references

Nino Stocchetti

8

0 references

Gordon Murray

object named as

Gordon Murray

2

0 references

author name string

Andrew I R Maas

1

1 reference

2 August 2017

Herbert Henney

3

1 reference

2 August 2017

Nadim Kassem

4

1 reference

2 August 2017

Valerie Legrand

5

1 reference

2 August 2017

Miriam Mangelus

6

1 reference

2 August 2017

Jan-Paul Muizelaar

7

1 reference

2 August 2017

Nachshon Knoller

9

1 reference

2 August 2017

Pharmos TBI investigators

10

1 reference

2 August 2017

1 January 2006

1 reference

2 August 2017

1 reference

2 August 2017

5

1 reference

2 August 2017

38-45

1 reference

2 August 2017

1

1 reference

2 August 2017

Traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

The Epidemiology of Traumatic Brain Injury: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Adverse reactions to intravenous anaesthetic induction agents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

EBIC-guidelines for management of severe head injury in adults. European Brain Injury Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

The Barthel ADL Index: a reliability study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Sample size review in a head injury trial with ordered categorical responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Clinical trials in head injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Clinical trials in traumatic brain injury: current problems and future solutions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Size and quality of randomised controlled trials in head injury: review of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

1 reference

7 January 2021

Pathophysiology of cerebral ischemia and brain trauma: similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Absent or compressed basal cisterns on first CT scan: ominous predictors of outcome in severe head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

Lack of effect of induction of hypothermia after acute brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970253-2

7 January 2021

10.1016/S1474-4422(05)70253-2

Identifiers

DOI

1 reference

2 August 2017

1 reference